Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	183.92	270.15	276.11	523.49	1,161	382.62
Short-Term Investments	518.19	601.14	50	50.95	-	-
Trading Asset Securities	398.69	201.51	280.02	888.68	927.45	-
Cash & Short-Term Investments	1,101	1,073	606.13	1,463	2,089	382.62
Cash Growth	43.61%	76.99%	-58.57%	-29.94%	445.84%	-9.51%
Accounts Receivable	122.63	92.49	28.59	102.04	38.21	29.13
Other Receivables	12.29	24.13	28.93	17.01	47.36	2.54
Receivables	134.92	116.62	57.52	119.06	85.57	31.68
Inventory	79.68	83.45	137.21	154.25	258.62	126.31
Prepaid Expenses	-	-	0.15	2.6	-	-
Other Current Assets	22.04	19.55	38.9	59.24	84.98	47.16
Total Current Assets	1,337	1,292	839.91	1,798	2,518	587.77
Property, Plant & Equipment	1,034	1,074	1,193	867.94	562.12	237.38
Long-Term Investments	741.75	826.04	1,418	1,038	441.6	-
Other Intangible Assets	50.21	52.12	55.07	56.55	57.33	58.45
Long-Term Deferred Tax Assets	33.16	26.64	34.4	38.8	15.95	3.15
Long-Term Deferred Charges	22.26	25.55	24.3	23.2	22.32	10.56
Other Long-Term Assets	26.42	29.3	6.76	76.21	27.85	5.21
Total Assets	3,245	3,326	3,572	3,899	3,645	902.52
Accounts Payable	55.49	46.12	44.72	151.52	141.27	66.24
Accrued Expenses	23.84	30.23	25.55	177.68	167.53	36.63
Short-Term Debt	50.03	-	-	-	-	-
Current Portion of Leases	0.08	0.12	7.49	27.95	13	-
Current Income Taxes Payable	1.28	1.06	1.15	1.13	120.24	16.7
Current Unearned Revenue	13.29	16.7	28.08	56.98	267.05	12.71
Other Current Liabilities	153.09	141.66	81.05	96.06	25.08	11.84
Total Current Liabilities	297.1	235.89	188.04	511.31	734.16	144.11
Long-Term Leases	0.1	0.12	7.76	14.18	22.98	-
Long-Term Unearned Revenue	13.62	15.75	9.77	10.77	9.47	9.61
Long-Term Deferred Tax Liabilities	0	-	-	9.32	4.41	2
Total Liabilities	310.83	251.77	205.57	545.59	771.01	155.72
Common Stock	92.71	92.47	92.27	92.05	62.2	62.2
Additional Paid-In Capital	335.06	321.41	444.04	435.31	458.31	449.85
Retained Earnings	2,702	2,786	2,994	2,958	2,323	230.85
Treasury Stock	-205.32	-133.89	-166.48	-150.04	-	-
Comprehensive Income & Other	13.6	9.96	4.32	-0.03	-0.3	-0.16
Total Common Equity	2,938	3,076	3,368	3,335	2,844	742.73
Minority Interest	-3.3	-1.43	-2.12	18.46	30.31	4.06
Shareholders' Equity	2,934	3,074	3,366	3,354	2,874	746.79
Total Liabilities & Equity	3,245	3,326	3,572	3,899	3,645	902.52
Total Debt	50.22	0.24	15.26	42.13	35.98	-
Net Cash (Debt)	1,051	1,073	590.87	1,421	2,053	382.62
Net Cash Growth	38.02%	81.52%	-58.42%	-30.77%	436.43%	-4.13%
Net Cash Per Share	11.51	11.61	6.69	15.46	22.30	4.15
Filing Date Shares Outstanding	88.83	89.58	89.41	89.53	92.05	92.05
Total Common Shares Outstanding	88.83	89.58	89.41	89.53	92.05	92.05
Working Capital	1,040	1,057	651.88	1,287	1,784	443.66
Book Value Per Share	33.07	34.33	37.67	37.25	30.89	8.07
Tangible Book Value	2,887	3,023	3,313	3,279	2,786	684.28
Tangible Book Value Per Share	32.50	33.75	37.06	36.62	30.27	7.43
Buildings	703.6	703.6	704.79	174.55	162.16	55.38
Machinery	554.79	567.73	575.66	399.88	317.94	196.3
Construction In Progress	5.67	5.62	48.18	374.44	121.71	55.45

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.